Mather Group’s Kura Oncology KURA Stock Holding History

Mather Group’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.25K	Buy	+117	New	+$1.31K	﹤0.01%	2129

Other funds holding KURA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Mather Group's KURA Position: Q3 2026 in Review

Mather Group opened a new position in Kura Oncology (KURA) in Q3 2026: 117 shares worth $1.25K. The stake represents ﹤0.01% of the portfolio and ranks #2129 among its holdings.

26 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

Mather Group held 117 shares of Kura Oncology worth $1.25K as of Q3 2026.
Kura Oncology was a new Mather Group position in Q3 2026.
Kura Oncology made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #2129 holding.
26 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.